Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology 1/2022
memo - Magazine of European Medical Oncology

Ausgabe 1/2022

share
TEILEN
insite
SUCHEN

Inhaltsverzeichnis (21 Artikel)

01.02.2022 | editorial

Innovative strategies in gastrointestinal cancer
Assoc.-Prof. PD Dr. Gerald Prager

01.02.2022 | editorial

New frontiers in chronic lymphocytic leukemia on the way to curing the disease
Univ.-Prof. Dr. Philipp Staber

01.02.2022 | editorial

Toxicity management in severe and refractory cases—what we have learned
Univ.-Prof. Dr. Matthias Preusser

03.02.2022 | short review

Hepatocellular carcinoma—neoadjuvant systemic and local treatment concepts to improve resectability rates and oncological outcome
Iveta Urban, Florian Primavesi, Klaus Bogner, Claudia Bartsch, Marlene Trattner, Alexandra Schmid, Stefan Stättner

10.06.2021 | case report

Thyroid metastasectomy for deposits from colorectal cancer: case report and non-systematic review
Waleed Elnahas, Islam H. Metwally, Wagdi Elkashef

27.01.2022 | short review

Immunotherapy—another breakthrough in gastrointestinal malignancies
Dr. Monika Lenzi, PD Dr. Thomas Winder PhD

Open Access 08.09.2021 | review

Neoadjuvant versus adjuvant management of resectable pancreas cancer: A review of the literature
PD OA Dr.med.univ. Konstantin Schlick

Open Access 19.10.2021 | short review

Innovative strategies in metastatic gastric cancer: a short review
Hannah Christina Puhr MD, Aysegul Ilhan-Mutlu MD PhD

22.12.2021 | short review

Practice-changing strategies in the treatment of esophageal cancer
Ercan Müldür MD, Wolfgang Hilbe MD

14.01.2022 | short review

Treatment decision based on molecular profiling in metastatic colorectal cancer with a focus on RAS pathway mutations
Johannes Schöche, Dora Niedersüß-Beke

Open Access 22.12.2021 | short review

Bcl2 inhibitor venetoclax +/− Anti-CD20: what do deep remissions mean?
Katharina T. Prochazka, Barbara Uhl

20.12.2021 | short review

BTKi, venetoclax, obinutuzumab: what is the ideal combination?
Daniel Heintel MD

Open Access 05.10.2021 | short review

New actionable targets and investigational drugs in chronic lymphocytic leukemia
Jan-Paul Bohn M.D., PhD

Open Access 09.09.2021 | case report

Immune-related hepatitis in a patient with hepatocellular carcinoma treated with nivolumab
Bernhard Scheiner MD, Matthias Pinter MD PhD

Open Access 06.10.2021 | short review

Checkpoint inhibitor pneumonitis: Short review of literature and case report
Romana Elisabeth Wass MD, PhD, David Lang MD, PhD, Andreas Horner MD, Bernd Lamprecht MD

Open Access 04.11.2021 | short review

Cardiotoxicity—current recommendations of prevention and treatment
A.o. Univ. Prof. Jutta Bergler-Klein MD, FESC, FEACVI, FHFA

Open Access 24.11.2021 | short review

Clinical challenges in the management of endocrine side effects of immuno-oncological therapies
Peter Wolf, Thomas Scherer

04.01.2022 | case report

Palliative care: patient’s autonomy in the end-of-life situation
Bert Engelhardt MD

26.10.2021 | case report

Chronic myeloid leukemia associated with acquired von Willebrand syndrome: A case report
Dr. Prachi Mohapatra MD, Dr. Satya Prasad Mahapatra MD

09.12.2021 | original report

The outcome of COVID-19 in patients with hematological malignancy
Pınar Tığlıoğlu, Murat Albayrak, Mesut Tığlıoğlu, Hacer Berna Afacan Öztürk, Merih Reis Aras, Buğra Sağlam, Senem Maral

22.11.2021 | original report

Clinical characteristics and prognostic value of 1q21 gain detected by fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma
Xiao Xiao, Xinchen Fang, Wen Yao, Zhu Huaiping